News

Targeted Oncology22h
Evaluating Neoadjuvant and Adjuvant Therapies and Benefits for MIBC
During a live event, Matthew Galsky, MD, discussed adjuvant and neoadjuvant treatment approaches for muscle-invasive bladder ...
Bladder Cancer Clinical Trial Analysis: Key Insights into Rich Pipeline Featuring 80+ Companies and 100+ Therapies | DelveInsight
In June 2025, Merck Sharp & Dohme LLC announced a study are to learn if people who receive intismeran autogene and ...